The FDA has approved GSK's gepotidacin, the first oral antibiotic to offer a new mechanism of action in uncomplicated urinary tract infections (uUTIs) in nearly 30 years, after a priority review.

Introduction Urinary tract infections (UTIs) are the second most common type of infection worldwide, accounting for a large number of primary care consultations and antibiotic prescribing. Current ...

We recently read the article of Song et al. on human biomonitoring of urinary metabolites of neonicotinoids with high interest. Our own experiments on the metabolism of imidacloprid after a single ...